Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Haptoglobin and ceruloplasmin in systemic scleroderma]

Z I Volkova, A S Kaĭnova, R M Balabanova

    Voprosy Meditsinskoi Khimii
    |May 1, 1977
    PubMed
    Summary

    This study found that scleroderma patients have lower ceruloplasmin and higher haptoglobin levels in their blood serum. These changes in haptoglobin and ceruloplasmin indicate the activity of the systemic scleroderma pathological process.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Interferons and other cytokines in rheumatic diseases].

    Vestnik Rossiiskoi akademii meditsinskikh nauk·2010
    Same author

    [Pneumonia in patients with rheumatoid arthritis: the frequency of development, the specific features of its course and risk factors].

    Terapevticheskii arkhiv·2010
    Same author

    [Herpesvirus infections in immunocompromised patients].

    Zhurnal mikrobiologii, epidemiologii i immunobiologii·2009
    Same author

    [Is antiviral therapy indicated in patients with rheumatological diseases?].

    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]·2007
    Same author

    [An antidestructive effect of leflunomide in early rheumatoid arthritis].

    Terapevticheskii arkhiv·2006
    Same author

    [Evaluation of rheumatoid arthritis activity in clinical practice].

    Terapevticheskii arkhiv·2005

    Area of Science:

    • Biochemistry
    • Immunology
    • Pathology

    Background:

    • Sclerodermia systematica is a complex autoimmune disease.
    • Haptoglobin and ceruloplasmin are acute-phase proteins synthesized in the liver.
    • Hepatic synthesis zones of these proteins are known.

    Purpose of the Study:

    • To investigate the levels of haptoglobin and ceruloplasmin in patients with sclerodermia systematica.
    • To correlate these protein levels with the activity of the pathological process.
    • To explore the relationship between hepatic localization of synthesis and observed serum concentrations.

    Main Methods:

    • Serum samples were collected from 23 patients diagnosed with sclerodermia systematica.
    • Quantitative estimation of haptoglobin and ceruloplasmin concentrations in blood serum was performed.

    Main Results:

    • A statistically significant decrease in ceruloplasmin concentration was observed in the blood serum of patients.
    • A marked increase in haptoglobin content was detected in the same patient cohort.
    • These alterations suggest a correlation between protein levels and disease activity.

    Conclusions:

    • The observed changes in haptoglobin and ceruloplasmin reflect the activity level of sclerodermia systematica.
    • Impaired hepatocytes in the peripheral zones of liver lobes likely contribute to the decreased ceruloplasmin levels.
    • Altered haptoglobin and ceruloplasmin concentrations serve as potential biomarkers for disease activity in scleroderma.

    Related Experiment Videos